Literature DB >> 34098105

Cellular stress responses and metabolic reprogramming in cancer progression and dormancy.

Kyle K Payne1.   

Abstract

Recurrent disease after prolonged cancer dormancy is a major cause of cancer associated mortality, yet many of the mechanisms that are engaged to initiate dormancy as well as later recurrence remain incompletely understood. It is known that cancer cells initiate adaptation mechanisms to adapt tightly regulated cellular processes to non-optimal growth environments; Recent investigations have begun to elucidate the contribution of these mechanisms to malignant progression, with intriguing studies now defining cellular stress as a key contributor to the development and maintenance of cancer dormancy. This review will focus on our current understanding of stress responses facilitating malignant cell adaptation and metabolic reprogramming to establish cancer dormancy.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer dormancy; Cancer recurrence; Endoplasmic reticulum stress; Metabolism; Oxidative stress

Mesh:

Year:  2021        PMID: 34098105      PMCID: PMC8642459          DOI: 10.1016/j.semcancer.2021.06.004

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  67 in total

Review 1.  Cancer, Oxidative Stress, and Metastasis.

Authors:  Jennifer G Gill; Elena Piskounova; Sean J Morrison
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2017-01-12

2.  Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression.

Authors:  Chih-Hao Chang; Jing Qiu; David O'Sullivan; Michael D Buck; Takuro Noguchi; Jonathan D Curtis; Qiongyu Chen; Mariel Gindin; Matthew M Gubin; Gerritje J W van der Windt; Elena Tonc; Robert D Schreiber; Edward J Pearce; Erika L Pearce
Journal:  Cell       Date:  2015-08-27       Impact factor: 41.582

3.  XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway.

Authors:  Dimitrios Iliopoulos; Qing Zhang; Qianzi Tang; Xi Chen; Matthew B Greenblatt; Maria Hatziapostolou; Elgene Lim; Wai Leong Tam; Min Ni; Yiwen Chen; Junhua Mai; Haifa Shen; Dorothy Z Hu; Stanley Adoro; Bella Hu; Minkyung Song; Chen Tan; Melissa D Landis; Mauro Ferrari; Sandra J Shin; Myles Brown; Jenny C Chang; X Shirley Liu; Laurie H Glimcher
Journal:  Nature       Date:  2014-03-23       Impact factor: 49.962

4.  Self-renewal of CD133(hi) cells by IL6/Notch3 signalling regulates endocrine resistance in metastatic breast cancer.

Authors:  Pasquale Sansone; Claudio Ceccarelli; Marjan Berishaj; Qing Chang; Vinagolu K Rajasekhar; Fabiana Perna; Robert L Bowman; Michele Vidone; Laura Daly; Jennifer Nnoli; Donatella Santini; Mario Taffurelli; Natalie N C Shih; Michael Feldman; Jun J Mao; Christopher Colameco; Jinbo Chen; Angela DeMichele; Nicola Fabbri; John H Healey; Monica Cricca; Giuseppe Gasparre; David Lyden; Massimiliano Bonafé; Jacqueline Bromberg
Journal:  Nat Commun       Date:  2016-02-09       Impact factor: 14.919

Review 5.  Hypoxia-Induced Oxidative Stress Modulation with Physical Activity.

Authors:  Tadej Debevec; Grégoire P Millet; Vincent Pialoux
Journal:  Front Physiol       Date:  2017-02-13       Impact factor: 4.566

Review 6.  Unfolded Protein Response (UPR) in Survival, Dormancy, Immunosuppression, Metastasis, and Treatments of Cancer Cells.

Authors:  Sheng-Kai Hsu; Chien-Chih Chiu; Hans-Uwe Dahms; Chon-Kit Chou; Chih-Mei Cheng; Wen-Tsan Chang; Kai-Chun Cheng; Hui-Min David Wang; I-Ling Lin
Journal:  Int J Mol Sci       Date:  2019-05-22       Impact factor: 5.923

7.  ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression.

Authors:  Yu Cao; Jimena Trillo-Tinoco; Rosa A Sierra; Carmen Anadon; Wenjie Dai; Eslam Mohamed; Ling Cen; Tara L Costich; Anthony Magliocco; Douglas Marchion; Richard Klar; Sven Michel; Frank Jaschinski; Richard R Reich; Shikhar Mehrotra; Juan R Cubillos-Ruiz; David H Munn; Jose R Conejo-Garcia; Paulo C Rodriguez
Journal:  Nat Commun       Date:  2019-03-20       Impact factor: 14.919

Review 8.  NRF2 and the Ambiguous Consequences of Its Activation during Initiation and the Subsequent Stages of Tumourigenesis.

Authors:  Holly Robertson; Albena T Dinkova-Kostova; John D Hayes
Journal:  Cancers (Basel)       Date:  2020-12-02       Impact factor: 6.639

Review 9.  The force awakens: metastatic dormant cancer cells.

Authors:  So-Yeon Park; Jeong-Seok Nam
Journal:  Exp Mol Med       Date:  2020-04-16       Impact factor: 8.718

10.  Local and distant tumor dormancy during early stage breast cancer are associated with the predominance of infiltrating T effector subsets.

Authors:  Hussein F Aqbi; Cara Coleman; Melika Zarei; Saeed H Manjili; Laura Graham; Jennifer Koblinski; Chunquing Guo; Yibin Xie; Georgi Guruli; Harry D Bear; Michael O Idowu; Mehran Habibi; Xiang-Yang Wang; Masoud H Manjili
Journal:  Breast Cancer Res       Date:  2020-10-28       Impact factor: 6.466

View more
  4 in total

1.  The Immunological Contribution of a Novel Metabolism-Related Signature to the Prognosis and Anti-Tumor Immunity in Cervical Cancer.

Authors:  Sihui Yu; Xi Li; Mingjun Ma; Rui Yang; Jiawen Zhang; Sufang Wu
Journal:  Cancers (Basel)       Date:  2022-05-13       Impact factor: 6.575

Review 2.  Cellular stress response to extremely low-frequency electromagnetic fields (ELF-EMF): An explanation for controversial effects of ELF-EMF on apoptosis.

Authors:  Mojdeh Barati; Behrad Darvishi; Mohammad Amin Javidi; Ali Mohammadian; Seyed Peyman Shariatpanahi; Mohammad Reza Eisavand; Alireza Madjid Ansari
Journal:  Cell Prolif       Date:  2021-11-06       Impact factor: 6.831

3.  AKR1C1 promotes non-small cell lung cancer proliferation via crosstalk between HIF-1α and metabolic reprogramming.

Authors:  Lin-Lin Chang; Pei-Hua Lu; Wei Yang; Yan Hu; Lin Zheng; Qiong Zhao; Neng-Ming Lin; Wen-Zhou Zhang
Journal:  Transl Oncol       Date:  2022-04-13       Impact factor: 4.803

4.  In vivo metabolic imaging identifies lipid vulnerability in a preclinical model of Her2+/Neu breast cancer residual disease and recurrence.

Authors:  Megan C Madonna; Joy E Duer; Brock J McKinney; Enakshi D Sunassee; Brian T Crouch; Olga Ilkayeva; Matthew D Hirschey; James V Alvarez; Nirmala Ramanujam
Journal:  NPJ Breast Cancer       Date:  2022-09-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.